Pre-existing and emerging immune-mediated diseases in patients with breast cancer undergoing cyclin-dependent kinases 4/6 inhibitors and endocrine therapyFlavia Jacobs, Rita De Sanctis, Chiara Andreottola et al.|The Oncologist|2025Cited by 5